Diseases Home > Menveo Vaccine Information

Menveo® (meningococcal vaccine) is one of a few available vaccines approved to protect against invasive meningococcal diseases, such as bacterial meningitis. It is approved for people between the ages of 11 and 55. There is only one recommended dose for this product, regardless of age or weight. At this time, a booster dose is not recommended, although this could change in the future.
The vaccine works by "tricking" the body into thinking it has been exposed to the actual bacteria, but without the risks of a real infection. If future exposure to the bacteria occurs, the immune system "remembers" the bacteria and is better able to fight it off.
Menveo is injected into a muscle, usually in the upper arm. Although most people do not develop any problems after receiving the vaccination, side effects may occur. Some of the most common reactions to Menveo include redness, pain, or swelling at the injection site.
(For more information on this vaccine, click Menveo. This article provides more in-depth dosing guidelines and explains why Menveo may not be suitable for everyone.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.